{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:18Z","timestamp":1792507518676,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,5]],"date-time":"2014-06-05T00:00:00Z","timestamp":1401926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s00296-014-3051-x","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T22:10:41Z","timestamp":1401919841000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":116,"title":["Identification of lymphoma predictors in patients with primary Sj\u00f6gren\u2019s syndrome: a systematic literature review and meta-analysis"],"prefix":"10.1007","volume":"35","author":[{"given":"Maria B.","family":"Nishishinya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A.","family":"Pereda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Pego-Reigosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I\u00f1igo","family":"R\u00faa-Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Luis","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Fern\u00e1ndez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Loza Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,5]]},"reference":[{"issue":"3","key":"3051_CR1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S1079-2104(96)80331-3","volume":"81","author":"RC Jordan","year":"1996","unstructured":"Jordan RC, Speight PM (1996) Lymphoma in Sjogren\u2019s syndrome. From histopathology to molecular pathology. Oral Surg Oral Med O 81(3):308\u2013320","journal-title":"Oral Surg Oral Med O"},{"issue":"6","key":"3051_CR2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89(6):888\u2013892","journal-title":"Ann Intern Med"},{"key":"3051_CR3","first-page":"337","volume":"1","author":"D Pariente","year":"1992","unstructured":"Pariente D, Anaya JM, Combe B, Jorgensen C, Emberger JM, Rossi JF et al (1992) Non-Hodgkin\u2019s lymphoma associated with primary Sjogren\u2019s syndrome. Eur J Med 1:337\u2013342","journal-title":"Eur J Med"},{"key":"3051_CR4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JPA Ioannidis","year":"2002","unstructured":"Ioannidis JPA, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome. Arthritis Rheum 46:741\u2013747","journal-title":"Arthritis Rheum"},{"key":"3051_CR5","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1158\/1055-9965.EPI-06-0300","volume":"15","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Baecklund E, Askling J (2006) Malignant lymphomas in autoimmunity and inflammation: a review of risks, risk factors, and lymphoma characteristics. Cancer Epidemiol Biomarkers Prev 15:2069\u20132077","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"3051_CR6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/jnci\/djj004","volume":"98","author":"KE Smedby","year":"2006","unstructured":"Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A et al (2006) Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 98:51\u201360","journal-title":"J Natl Cancer Inst"},{"key":"3051_CR7","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.165.20.2337","volume":"165","author":"E Zintzaras","year":"2005","unstructured":"Zintzaras E, Voulgarelis M, Moutsopoulos HM (2005) The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165:2337\u20132344","journal-title":"Arch Intern Med"},{"key":"3051_CR8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12016-007-8001-x","volume":"32","author":"M Voulgarelis","year":"2007","unstructured":"Voulgarelis M, Skopouli FN (2007) Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren\u2019s syndrome patients. Clin Rev Allergy Immunol 32:265\u2013274","journal-title":"Clin Rev Allergy Immunol"},{"key":"3051_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0049-0172(96)80019-9","volume":"25","author":"JM Anaya","year":"1996","unstructured":"Anaya JM, McGuff HS, Banks PM, Talal N (1996) Clinicopathological factors relating malignant lymphoma with Sjogren\u2019s syndrome. Semin Arthritis Rheum 25:337\u2013346","journal-title":"Semin Arthritis Rheum"},{"key":"3051_CR10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/00016489609137948","volume":"116","author":"D Biasi","year":"1996","unstructured":"Biasi D, Mocella S, Caramaschi P et al (1996) Utility and safety of parotid gland biopsy in Sjogren\u2019s syndrome. Acta Otolaryngol 116:896\u2013899","journal-title":"Acta Otolaryngol"},{"key":"3051_CR11","unstructured":"Oxford Centre for Evidence-Based Medicine (2011) OCEBM Levels of Evidence Working Group*. \u201cThe Oxford 2011 Levels of Evidence\u201d. http:\/\/www.cebm.net\/index.aspx?o=5653"},{"key":"3051_CR12","doi-asserted-by":"crossref","first-page":"888","DOI":"10.7326\/0003-4819-89-6-888","volume":"89","author":"SS Kassan","year":"1978","unstructured":"Kassan SS, Thomas TL, Moutsopoulos HM, Hoover R, Kimberly RP, Budman DR et al (1978) Increased risk of lymphoma in sicca syndrome. Ann Intern Med 89:888\u2013892","journal-title":"Ann Intern Med"},{"key":"3051_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/MD.0b013e3181b76ab5","volume":"88","author":"E Baimpa","year":"2009","unstructured":"Baimpa E, Dahabreh IJ, Voulgarelis M, Moutsopoulos HM (2009) Hematologic manifestations and predictors of lymphoma development in primary Sjogren syndrome: clinical and pathophysiologic aspects. Medicine (Baltimore) 88:284\u2013293","journal-title":"Medicine (Baltimore)"},{"key":"3051_CR14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1093\/rheumatology\/kem079","volume":"46","author":"P Brito-Zeron","year":"2007","unstructured":"Brito-Zeron P, Ramos-Casals M, Bove A, Sentis J, Font J (2007) Predicting adverse outcomes in primary Sjogren\u2019s syndrome: identification of prognostic factors. Rheumatology 46:1359\u20131362","journal-title":"Rheumatology"},{"key":"3051_CR15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/rheumatology\/38.3.245","volume":"38","author":"BKS Davidson","year":"1999","unstructured":"Davidson BKS, Kelly CA, Griffiths ID (1999) Primary Sjogren\u2019s syndrome in the North East of England: a long-term follow-up study. Rheumatology 38:245\u2013253","journal-title":"Rheumatology"},{"key":"3051_CR16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/art.10221","volume":"46","author":"JP Ioannidis","year":"2002","unstructured":"Ioannidis JP, Vassiliou VA, Moutsopoulos HM (2002) Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren\u2019s syndrome. Arthritis Rheum 46:741\u2013747","journal-title":"Arthritis Rheum"},{"key":"3051_CR17","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/A:1018472213872","volume":"8","author":"M Kauppi","year":"1997","unstructured":"Kauppi M, Pukkala E, Isomaki H (1997) Elevated incidence of hematologic malignancies in patients with Sjogren\u2019s syndrome compared with patients with rheumatoid arthritis (Finland). Cancer Cause Control 8:201\u2013204","journal-title":"Cancer Cause Control"},{"key":"3051_CR18","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/rheumatology\/kei281","volume":"45","author":"MN Lazarus","year":"2006","unstructured":"Lazarus MN, Robinson D, Mak V, Moller H, Isenberg DA (2006) Incidence of cancer in a cohort of patients with primary Sjogren\u2019s syndrome. Rheumatology 45:1012\u20131015","journal-title":"Rheumatology"},{"key":"3051_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10875-011-9553-3","volume":"31","author":"C Martel","year":"2011","unstructured":"Martel C, Gondran G, Launay D, Lallou\u00e9 F, Palat S, Lambert M et al (2011) Active immunological profile is associated with systemic Sjogren\u2019s syndrome. J Clin Immunol 31:1\u20138","journal-title":"J Clin Immunol"},{"key":"3051_CR20","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1136\/ard.60.5.467","volume":"60","author":"M Pertovaara","year":"2001","unstructured":"Pertovaara M, Pukkala E, Laippala P, Miettinen A, Pasternack A (2001) A longitudinal cohort study of Finnish patients with primary Sjogren\u2019s syndrome: clinical, immunological, and epidemiological aspects. Ann Rheum Dis 60:467\u2013472","journal-title":"Ann Rheum Dis"},{"key":"3051_CR21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0049-0172(00)80016-5","volume":"29","author":"FN Skopouli","year":"2000","unstructured":"Skopouli FN, Dafni U, Ioannidis JPA, Moutsopoulos HM (2000) Clinical evolution, and morbidity and mortality of primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 29:296\u2013304","journal-title":"Semin Arthritis Rheum"},{"key":"3051_CR22","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0049-0172(98)80040-1","volume":"28","author":"N Sutcliffe","year":"1998","unstructured":"Sutcliffe N, Inanc M, Speight P, Isenberg D (1998) Predictors of lymphoma development in primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 28:80\u201387","journal-title":"Semin Arthritis Rheum"},{"key":"3051_CR23","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LT (2006) Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796\u2013803","journal-title":"Ann Rheum Dis"},{"key":"3051_CR24","first-page":"2376","volume":"24","author":"G Valesini","year":"1997","unstructured":"Valesini G, Priori R, Bavoillot D, Osborn J, Danieli G, Del Papa N et al (1997) Differential risk of non-Hodgkin\u2019s lymphoma in Italian patients with primary Sjogren\u2019s syndrome. J Rheumatol 24:2376\u20132380","journal-title":"J Rheumatol"},{"key":"3051_CR25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/rheumatology\/kep404","volume":"49","author":"W Zhang","year":"2010","unstructured":"Zhang W, Feng S, Yan S, Zhao Y, Li M, Sun J et al (2010) Incidence of malignancy in primary Sjogren\u2019s syndrome in a Chinese cohort. Rheumatology 49:571\u2013577","journal-title":"Rheumatology"},{"key":"3051_CR26","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","volume":"111","author":"KE Smedby","year":"2008","unstructured":"Smedby KE, Vajdic CM, Falster M et al (2008) Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111:4029\u20134038","journal-title":"Blood"},{"key":"3051_CR27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.semarthrit.2011.04.006","volume":"41","author":"R Solans-Laque","year":"2011","unstructured":"Solans-Laque R, Lopez-Hernandez A, Angel Bosch-Gil J, Palacios A, Campillo M, Vilardell-Tarres M (2011) Risk, predictors, and clinical characteristics of lymphoma development in primary Sjogren\u2019s syndrome. Semin Arthritis Rheum 41:415\u2013423","journal-title":"Semin Arthritis Rheum"},{"key":"3051_CR28","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780360309","volume":"36","author":"C Vitali","year":"1993","unstructured":"Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM et al (1993) Preliminary criteria for the classification of Sj\u00f6gren\u2019s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 36:340\u2013347","journal-title":"Arthritis Rheum"},{"key":"3051_CR29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, Motsopulos HM, Alexander EL, Carsons SE et al (2002) Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554\u2013558","journal-title":"Ann Rheum Dis"},{"key":"3051_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/art.1780290501","volume":"29","author":"RIRC Fox","year":"1986","unstructured":"Fox RIRC, Curd JG, Kozin F, Howell FV (1986) Sj\u00f6gren\u2019s syndrome. Proposed criteria for classification. Arthritis Rheum 29:577\u2013585","journal-title":"Arthritis Rheum"},{"key":"3051_CR31","doi-asserted-by":"crossref","unstructured":"Manthorpe R, Oxholm P, Prause JU, Schi\u00f8dt M (1986) The copenhagen criteria for Sj\u00f6gren\u2019s syndrome. Scand J Rheumatol Suppl 61:19\u201321","DOI":"10.1080\/15027732.1986.12461371"},{"key":"3051_CR32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H et al (2012) American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance Cohort. Arthritis Care Res 64:475\u2013487","journal-title":"Arthritis Care Res"},{"key":"3051_CR33","doi-asserted-by":"crossref","unstructured":"Liang Y, Yang Z, Qin B, Zhong R (2013) Primary Sj\u00f6gren\u00b4s syndrome and malignancy risk: a systematic review and meta-analysis. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-203305","DOI":"10.1136\/annrheumdis-2013-203305"},{"key":"3051_CR34","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/acr.21887","volume":"65","author":"SJBJG Johnsen","year":"2013","unstructured":"Johnsen SJBJG, Goransson LG, Smastuen MC, Johannesen TB, Haldorsen K et al (2013) Risk of non-Hodgkin\u00b4s lymphoma in primary Sj\u00f6gren`s syndrome: a population-based study. Arthritis Care Res 65:816\u2013821","journal-title":"Arthritis Care Res"},{"key":"3051_CR35","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.semarthrit.2013.03.001","volume":"43","author":"AP Risselada","year":"2013","unstructured":"Risselada AP, Kruize AA, Bijlsma JW (2013) Clinical features distinguishing lymphoma development in primary Sj\u00f6gren\u00b4s syndome\u2014a retrospective cohort study. Semin Arthritis Rheum 43:171\u2013177. doi: 10.1016\/j.semarthrit.2013.03.001","journal-title":"Semin Arthritis Rheum"},{"key":"3051_CR36","author":"L Quartuccio","year":"2013","unstructured":"Quartuccio L, Isola M, Baldini C, Priori R, Bartoloni Bocci E, Carubbi F et al (2013) Biomarkers of Lymphoma in Sj\u00f6gren`s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. J Autoimmun. doi: 10.1016\/j.jaut.2013.10.002","journal-title":"J Autoimmun"},{"key":"3051_CR37","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/art.20176","volume":"50","author":"E Theander","year":"2004","unstructured":"Theander E, Manthorpe R, Jacobsson LTH (2004) Mortality and causes of death in primary Sj\u00f6gren syndrome. Arthritis Rheum 50:1262\u20131269","journal-title":"Arthritis Rheum"},{"key":"3051_CR38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/ard.2005.041186","volume":"65","author":"E Theander","year":"2006","unstructured":"Theander E, Henriksson G, Ljungberg O, Mandl T, Manthorpe R, Jacobsson LTH (2006) Lymphoma and other malignancies in primary Sjogren\u2019s syndrome: a cohort study on cancer incidence and lymphoma predictors. Ann Rheum Dis 65:796\u2013803","journal-title":"Ann Rheum Dis"},{"key":"3051_CR39","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1573395511309010003","volume":"9","author":"LCY Dong","year":"2013","unstructured":"Dong LCY, Masaki Y, Okazaki T, Umehara H (2013) Possible mechanisms of lymphoma development in Sj\u00f6gren\u2019s syndrome. Curr Immunol Rev 9:13\u201322","journal-title":"Curr Immunol Rev"},{"key":"3051_CR40","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semarthrit.2013.04.004","volume":"43","author":"JGGJ Routsias","year":"2013","unstructured":"Routsias JGGJ, Georgios Charalampakis DMD, Tzima S, Papageorgiou A, Voulgarelis M (2013) Malignant lymphoma in primary Sj\u00f6gren syndrome: an update on the pathogenesis and treatment. Semin Arthritis Rheum 43:178\u2013186","journal-title":"Semin Arthritis Rheum"},{"key":"3051_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1157\/13115353","volume":"130","author":"P Brito-Zeron","year":"2008","unstructured":"Brito-Zeron P, Ramos-Casals M (2008) Prognosis of patients with primary Sjogren\u2019s syndrome. Med Clin (Barc) 130:109\u2013115","journal-title":"Med Clin (Barc)"},{"key":"3051_CR42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","volume":"70","author":"E Theander","year":"2011","unstructured":"Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R et al (2011) Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjogren\u2019s syndrome. Ann Rheum Dis 70:1363\u20131368","journal-title":"Ann Rheum Dis"},{"key":"3051_CR43","author":"A Nezos","year":"2013","unstructured":"Nezos A, Papageorgiou A, Fragoulis G, Loakeimidis D, Koutsilieris M, Tzioufas AG et al (2013) B-cell activating factor genetic variants in lymphomagenesis associated with primary Sj\u00f6gren\u00b4s syndrome. J Autoimmun. doi: 10.1016\/j.jaut.2013.04.005","journal-title":"J Autoimmun"},{"key":"3051_CR44","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/art.38129","volume":"65","author":"GJSA Tob\u00f3n","year":"2013","unstructured":"Tob\u00f3n GJSA, Gottenberg J-E, Quartuccio L, Fabris M, Seror R et al (2013) Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sj\u00f6gren\u00b4s syndrome. Arthritis Rheum 65:3218","journal-title":"Arthritis Rheum"},{"key":"3051_CR45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000046539","volume":"105","author":"D Biasi","year":"2001","unstructured":"Biasi D, Caramaschi P, Ambrosetti A et al (2001) Mucosa-associated lymphoid tissue lymphoma of the salivary glands occurring in patients affected by Sjogren\u2019s syndrome: report of 6 cases. Acta Haematol 105:83\u201388","journal-title":"Acta Haematol"},{"key":"3051_CR46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/03009749509095178","volume":"24","author":"P Zufferey","year":"1995","unstructured":"Zufferey P, Meyer OC, Grossin M, Kahn MF (1995) Primary Sjogren\u2019s syndrome (SS) and malignant lymphoma. A retrospective cohort study of 55 patients with SS. Scand J Rheumatol 24:342\u2013345","journal-title":"Scand J Rheumatol"},{"key":"3051_CR47","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00296-012-2464-7","volume":"33","author":"F Ismail","year":"2012","unstructured":"Ismail F, Mahmoud A, Abdelhaleem H, Mamdoh A, Geneidy M, Kamal E (2012) Primary Sj\u00f6gren\u2019s syndrome and B-non-Hodgkin lymphoma: role of CD4+ T lymphocytopenia. Rheumatol Int 33:1021\u20131025","journal-title":"Rheumatol Int"},{"key":"3051_CR48","author":"JM Kramer","year":"2014","unstructured":"Kramer JM (2014) Early events in Sj\u00f6gren\u2019s syndrome pathogenesis: the importance of innate immunity in disease initiation. Cytokine. doi: 10.1016\/j.cyto.2014.02.009","journal-title":"Cytokine"},{"key":"3051_CR49","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/annrheumdis-2011-200402","volume":"71","author":"MY Weng","year":"2012","unstructured":"Weng MY, Huang YT, Liu MF, Lu TH (2012) Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sj\u00f6gren\u00b4s syndrome in Taiwan. Ann Rheum Dis 71:524\u2013527","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3051-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-014-3051-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-014-3051-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:01:47Z","timestamp":1746255707000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-014-3051-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,5]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["3051"],"URL":"https:\/\/doi.org\/10.1007\/s00296-014-3051-x","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,5]]}}}